NCT03760003 2025-11-28
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
Abivax S.A.
Phase 2 Completed
Clinical Trials
5 trialsNCT01520324 2019-02-08
Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy
CosmoTech
Phase 2 Completed
NCT01959282 2019-01-04
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC
Phase 2 Completed
NCT00727324 2012-04-02
Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis
AM-Pharma
Phase 2 Completed
NCT00676832 2010-09-29
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
Prometheus Laboratories
Phase 2 Completed